Literature DB >> 24655892

An update from the United States National Heart, Lung, and Blood Institute-funded Production Assistance for Cellular Therapies (PACT) program: a decade of cell therapy.

Deborah Wood1, Robin Wesselschmidt, Peiman Hematti, Adrian P Gee, Cliona Rooney, Leslie Silberstein, Myriam Armant, Larry Couture, John E Wagner, David H McKenna, Derek Hei, Traci Heath Mondoro, Lisbeth Welniak, Robert Lindblad.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24655892      PMCID： PMC4006308          DOI： 10.1111/cts.12148

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN： 1752-8054            Impact factor:   4.689


× No keyword cloud information.
  50 in total

1.  Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell.

Authors:  D S Krause; N D Theise; M I Collector; O Henegariu; S Hwang; R Gardner; S Neutzel; S J Sharkis
Journal:  Cell       Date:  2001-05-04       Impact factor: 41.582

2.  A multicenter comparison study between the Endosafe PTS rapid-release testing system and traditional methods for detecting endotoxin in cell-therapy products.

Authors:  A P Gee; D Sumstad; J Stanson; P Watson; J Proctor; D Kadidlo; E Koch; J Sprague; D Wood; D Styers; D McKenna; J Gallelli; D Griffin; E J Read; B Parish; R Lindblad
Journal:  Cytotherapy       Date:  2008       Impact factor: 5.414

3.  Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virus-associated lymphoma.

Authors:  Catherine M Bollard; Stephen Gottschalk; M Helen Huls; Ann M Leen; Adrian P Gee; Cliona M Rooney
Journal:  Cytotherapy       Date:  2011-03-01       Impact factor: 5.414

4.  Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children.

Authors:  Charles S Cox; James E Baumgartner; Matthew T Harting; Laura L Worth; Peter A Walker; Shinil K Shah; Linda Ewing-Cobbs; Khader M Hasan; Mary-Clare Day; Dean Lee; Fernando Jimenez; Adrian Gee
Journal:  Neurosurgery       Date:  2011-03       Impact factor: 4.654

5.  Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity.

Authors:  Keli L Hippen; Sarah C Merkel; Dawn K Schirm; Christine M Sieben; Darin Sumstad; Diane M Kadidlo; David H McKenna; Jonathan S Bromberg; Bruce L Levine; James L Riley; Carl H June; Phillip Scheinberg; Daniel C Douek; Jeffrey S Miller; John E Wagner; Bruce R Blazar
Journal:  Sci Transl Med       Date:  2011-05-18       Impact factor: 17.956

6.  Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.

Authors:  Claudio G Brunstein; Jeffrey S Miller; Qing Cao; David H McKenna; Keli L Hippen; Julie Curtsinger; Todd Defor; Bruce L Levine; Carl H June; Pablo Rubinstein; Philip B McGlave; Bruce R Blazar; John E Wagner
Journal:  Blood       Date:  2010-10-15       Impact factor: 22.113

Review 7.  Production Assistance for Cellular Therapies (PACT): four-year experience from the United States National Heart, Lung, and Blood Institute (NHLBI) contract research program in cell and tissue therapies.

Authors:  William Reed; Stephen J Noga; Adrian P Gee; Cliona M Rooney; John E Wagner; Jeffrey McCullough; David H McKenna; Theresa L Whiteside; Albert D Donnenberg; Acacia K Baker; Robert W Lindblad; Elizabeth L Wagner; Traci Heath Mondoro
Journal:  Transfusion       Date:  2008-12-23       Impact factor: 3.157

8.  Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction.

Authors:  Jay H Traverse; Timothy D Henry; Douglas E Vaughan; Douglas E Vaughn; Stephen G Ellis; Carl J Pepine; James T Willerson; David X M Zhao; Linda B Piller; Marc S Penn; Barry J Byrne; Emerson C Perin; Adrian P Gee; Antonis K Hatzopoulos; David H McKenna; John R Forder; Doris A Taylor; Christopher R Cogle; Rachel E Olson; Beth C Jorgenson; Shelly L Sayre; Rachel W Vojvodic; David J Gordon; Sonia I Skarlatos; Lemuel A Moye'; Robert D Simari
Journal:  Am Heart J       Date:  2009-07-23       Impact factor: 4.749

9.  Generation of multivirus-specific T cells to prevent/treat viral infections after allogeneic hematopoietic stem cell transplant.

Authors:  Ulrike Gerdemann; Juan F Vera; Cliona M Rooney; Ann M Leen
Journal:  J Vis Exp       Date:  2011-05-27       Impact factor: 1.355

10.  Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection.

Authors:  Theresa L Whiteside; Paolo Piazza; Amanda Reiter; Joanna Stanson; Nancy C Connolly; Charles R Rinaldo; Sharon A Riddler
Journal:  Clin Vaccine Immunol       Date:  2008-11-26
View more
  2 in total

1.  A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression.

Authors:  Debra D Bloom; John M Centanni; Neehar Bhatia; Carol A Emler; Diana Drier; Glen E Leverson; David H McKenna; Adrian P Gee; Robert Lindblad; Derek J Hei; Peiman Hematti
Journal:  Cytotherapy       Date:  2014-11-21       Impact factor: 5.414

Review 2.  Cell therapy product administration and safety: data capture and analysis from the Production Assistance for Cellular Therapies (PACT) program.

Authors:  Robert W Lindblad; Laarni Ibenana; John E Wagner; David H McKenna; Derek J Hei; Peiman Hematti; Larry A Couture; Leslie E Silberstein; Myriam Armant; Cliona M Rooney; Adrian P Gee; Lisbeth A Welniak; Traci Heath Mondoro; Deborah A Wood; David Styers
Journal:  Transfusion       Date:  2014-10-14       Impact factor: 3.157
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.